OBJECTIVE: We examined correlates of continued smoking versus cessation among a sample of survivors of smoking-related cancers who were actively smoking at the time of cancer diagnosis. METHODS: Participants with a history of smoking and a smoking-related cancer diagnosis (lung, oral, pharynx, larynx, esophagus, bladder, stomach, cervix, kidney, pancreas, acute myeloid leukemia) within the past 4 years were identified in the electronic medical record. We recruited 613 individuals to complete a mail-based survey and received 139 completed surveys (22.7% response rate). We focused on 105 participants who smoked at the time of diagnosis and dichotomized them to having either quit since diagnosis (48.6%; n = 51) or continued smoking (51.4%; n = 54). We assessed sociodemographics, type of cancer and treatment(s), and psychosocial factors (depressive symptoms, social support, hope, quality of life). We then conducted structured interviews with a subset of 21 survey respondents. RESULTS: Binary logistic regression indicated that, controlling for age, gender, ethnicity, marital status, and income, factors associated with continued smoking versus cessation included being diagnosed with other smoking-related cancers versus lung or head and neck cancer (OR = 11.21, CI 2.85, 44.02) and having significant depressive symptoms (OR = 1.25, CI 1.08, 1.45). Qualitative findings highlighted motivators for cessation (impact of being diagnosed with cancer, doctor advice to quit, social influences) and barriers to cessation (hopelessness, stress, addiction). CONCLUSIONS: These findings highlight the need to address depressive symptoms among cancer survivors, particularly those continuing to smoke and the importance of exploring messages cancer survivors are given regarding the need for cessation post cancer diagnosis.
OBJECTIVE: We examined correlates of continued smoking versus cessation among a sample of survivors of smoking-related cancers who were actively smoking at the time of cancer diagnosis. METHODS:Participants with a history of smoking and a smoking-related cancer diagnosis (lung, oral, pharynx, larynx, esophagus, bladder, stomach, cervix, kidney, pancreas, acute myeloid leukemia) within the past 4 years were identified in the electronic medical record. We recruited 613 individuals to complete a mail-based survey and received 139 completed surveys (22.7% response rate). We focused on 105 participants who smoked at the time of diagnosis and dichotomized them to having either quit since diagnosis (48.6%; n = 51) or continued smoking (51.4%; n = 54). We assessed sociodemographics, type of cancer and treatment(s), and psychosocial factors (depressive symptoms, social support, hope, quality of life). We then conducted structured interviews with a subset of 21 survey respondents. RESULTS: Binary logistic regression indicated that, controlling for age, gender, ethnicity, marital status, and income, factors associated with continued smoking versus cessation included being diagnosed with other smoking-related cancers versus lung or head and neck cancer (OR = 11.21, CI 2.85, 44.02) and having significant depressive symptoms (OR = 1.25, CI 1.08, 1.45). Qualitative findings highlighted motivators for cessation (impact of being diagnosed with cancer, doctor advice to quit, social influences) and barriers to cessation (hopelessness, stress, addiction). CONCLUSIONS: These findings highlight the need to address depressive symptoms among cancer survivors, particularly those continuing to smoke and the importance of exploring messages cancer survivors are given regarding the need for cessation post cancer diagnosis.
Authors: G E Richardson; M A Tucker; D J Venzon; R I Linnoila; R Phelps; J C Phares; M Edison; D C Ihde; B E Johnson Journal: Ann Intern Med Date: 1993-09-01 Impact factor: 25.391
Authors: D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon Journal: J Clin Oncol Date: 1993-03 Impact factor: 44.544
Authors: G P Browman; G Wong; I Hodson; J Sathya; R Russell; L McAlpine; P Skingley; M N Levine Journal: N Engl J Med Date: 1993-01-21 Impact factor: 91.245
Authors: Katherine R Sterba; Elizabeth Garrett-Mayer; Matthew J Carpenter; Janet A Tooze; Jeanne L Hatcher; Christopher Sullivan; Lee Anne Tetrick; Graham W Warren; Terrence A Day; Anthony J Alberg; Kathryn E Weaver Journal: Laryngoscope Date: 2016-07-09 Impact factor: 3.325
Authors: Allison J Carroll; Anna K Veluz-Wilkins; Sonja Blazekovic; Ravi Kalhan; Frank T Leone; E Paul Wileyto; Robert A Schnoll; Brian Hitsman Journal: Psychooncology Date: 2017-08-04 Impact factor: 3.894
Authors: Diana S Hoover; Claire A Spears; Damon J Vidrine; Joan L Walker; Ya-Chen Tina Shih; David W Wetter Journal: Am J Health Behav Date: 2019-05-01
Authors: H Naik; X Qiu; M C Brown; L Eng; D Pringle; M Mahler; H Hon; K Tiessen; H Thai; V Ho; C Gonos; R Charow; V Pat; M Irwin; L Herzog; A Ho; W Xu; J M Jones; D Howell; G Liu Journal: Curr Oncol Date: 2016-12-21 Impact factor: 3.677
Authors: M Shayne Gallaway; Bin Huang; Quan Chen; Thomas C Tucker; Jaclyn K McDowell; Eric Durbin; Sherri L Stewart; Eric Tai Journal: J Community Health Date: 2019-06
Authors: Yael R Symes; Kurt M Ribisl; Marcella H Boynton; J Lee Westmaas; Deborah K Mayer; Shelley D Golden Journal: J Cancer Surviv Date: 2019-01-24 Impact factor: 4.442
Authors: Erika Litvin Bloom; Jason A Oliver; Steven K Sutton; Thomas H Brandon; Paul B Jacobsen; Vani Nath Simmons Journal: Psychooncology Date: 2014-09-25 Impact factor: 3.894
Authors: Carla J Berg; Robin C Vanderpool; Betelihem Getachew; Jackelyn B Payne; Meghan F Johnson; Yasmeni Sandridge; Jennifer Bierhoff; Lana Le; Rakiyah Johnson; Amber Weber; Akilah Patterson; Sarah Dorvil; Ann Mertens Journal: J Cancer Educ Date: 2020-12 Impact factor: 2.037
Authors: Jessica L Burris; Jamie L Studts; Antonio P DeRosa; Jamie S Ostroff Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-08-17 Impact factor: 4.254